@officialcipla

@officialcipla has been a member of Linktree for 5 years and joined in April 2021. Resources officialcipla has populated their site with include: • Cipla Archives Virtual Tour • www.cipla.com • Cipla partners with ImmunoACT to launch talicabtagene autoleucel, an anti-CD19 CAR-T cell therapy for blood cancers in Africa • Cipla launches Yurpeak® for the treatment of Obesity and Type 2 Diabetes • Cipla partners with Stempeutics, launches Stem Cell Therapy for Knee Osteoarthritis • Cipla Launches India’s First Dedicated Lung Health Diagnostics Center in Delhi • Introducing BreatheFree UAE • Lilly and Cipla sign an agreement for distribution of Yurpeak® • Cipla introduces HUENA®- India's first non-antibiotic drug for recurring urinary tract infections. • Umang Vohra on What makes a nation healthy? Revisiting the starting line • Cipla invests in ICaltech Innovations to strengthen respiratory care. • Exclusive | Achin Gupta – At 90, Cipla soars with dedication, and the unwavering pulse of 'Caring for Life' • Integrated Annual Report 2024-2025 • COVID-19 in todays era Clearing the air • Cipla becomes first to launch Plazomicin in India, leading the charge against AMR • Q4 & FY25 results Operational Excellence Driving Growth • Episode 3 of Sehat Pe Charcha | Cipla • Cipla Foundation and CanSupport Launch Maharashtra’s Largest Palliative Home Care Service in Pune • Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension • Morning Brief Podcast: Corner Office Conversation With Umang Vohra • Ciplamed Flix HSS Register link • Introducing CipAir ®️, an AI-powered mobile application • Episode 2 of Sehat Pe Charcha | Cipla • Cipla x Mannkind - Revolutionary step in diabetes care • Episode 1 of Sehat Pe Charcha | Cipla • Cipla Financial Results: Q2FY25 Highlights • Cipla x Ethris • Cipla receives final approval for the generic version of Somatuline® Depot (lanreotide) Injection | Cipla • Cipla x Achira • Cipla Financial Results: Q4 & Full Year FY24 Highlights • Cipla Palliative Care Annual Update 2023-2024 • Cipla Health strengthens its play in beauty and personal care | Cipla • Cipla x • Upul Tharanga - An untold tale of Asthma • Cipla secures approval to introduce ZEMDRI® (plazomicin) injection in India | Cipla • Illness to Wellness - Umang Vohra • Rewiring India’s healthcare ecosystem for wellness (indiatimes.com) • Respiratory drug Foracort No. 1 in sales - Times of India • Cipla Announces JV | Press Release • HSS 17 T&C • HSS 17 Registration • Cipla | GoApptiv • Cipla TEACH Pogram • Cipla Annual Report 2022-23 • View: Preventive MedTech is about to enter period of rapid change • Cipla Financial Results: Q4 & Full Year FY23 • LUNG FORCE Walk New York City 2023 • Take An Anemia Test | Iron Deficiency Test for Children • Cipla: No. 1 in Respiratory Care in India - Times of India • Breathefree: Lung Health App - Apps on Google Play • Inviting women professionals to come join our team • India Needs Novel Healthcare Innovations To Drive Wellness In India's Hinterlands - Forbes India Blogs • Plants of the Future: Building efficient manufacturing ecosystems • Cipla certified as a Great Place to Work for the fifth year in a row • Cipla Q3 FY23 Results • Pink of Health • Cipla launches Cippoint – a point-of-care device for Non-Communicable Diseases, infectious diseases, and other health conditions | Cipla • Cipla - Milestones & awards | Pharmaceutical products provider • Cipla EU to Invest EUR 15 million in Ethris, initiating a strategic collaboration | Cipla • Cipla's higher automation spends to continue for 3 more years: CTO Geena Malhotra, Health News, ET HealthWorld • Rising cost of raw materials a challenge for drug firms: Cipla's Hamied • Nepal has the highest death rate from chronic obstructive pulmonary disease, study reveals • The pertinence of palliative care in India’s care protocol • The Global Boardroom — 7-9 December, 2022, online - Financial Times x TNW • Exclusive Interview: Dr Raju Mistry, President and Global Chief People Officer, Cipla - ETHRWorld • Community Food Bank of NJ | Providing Food, Help & Hope‎ • Cipla announces launch of leuprolide acetate injection depot (22.5mg) | Cipla • Register for Ciplamed flix Healthcare Superstars Episode 13 • Diversity is welcome in the pharma industry, says Cipla's Raju Mistry • Smoking accounts for 35% of global COPD cases • What is COPD? • Webinar - Decoding Chronic Obstructive Pulmonary Disease (COPD) • Watch Now | "The Indian pharma markets are now one of the main growth engines for Indian pharma cos," says Cipla' Umang Vohra in an exclusive chat with Nikunj Dalmia • From Goldman to Cipla, finding her feet and leadership mantras over the last decade: Samina Hamied • LIVE on ET NOW - Cipla's MD & Global CEO Umang Vohra in an exclusive chat with Nikunj Dalmia • Cipla bets on digitisation to raise the bar on productivity • Cipla Indore's OSD plant designated as an ‘Advanced Fourth Industrial Revolution (4IR) Lighthouse’ by the World Economic Forum. • Join our LinkedIn family • Rewiring India’s healthcare ecosystem for wellness • Cipla receives USFDA approval for generic version of Revlimid® (Lenalidomide capsules) • Indian philanthropy has a worthy record that could shine brighter • Download the Breathefree App • Asthma ke liye #InhalersHainSahi Song I Kathak Dance Video • Presenting Cipla's 2021-22 Integrated Annual Report. • Let The Battle For Air Begin • Cipla to further invest in digital tech company GoApptiv to hold 22.02% stake post completion of proposed transaction • Cipla signs agreement for acquisition of 21.05% stake in Achira Labs to develop affordable, innovative medical kits in India • Cipla and DNDi launch child-friendly 4-in-1 antiretroviral treatment for young children living with HIV in South Africa • "Working With People Is Energy Booster" • Nico the Chatbot by Nicotex • What is Allergic Rhinitis? (Uncommon Cold) • Cipla adds capacity of captive renewable energy power plant in Maharashtra & Karnataka • Cipla scores highest among pharma companies in CRISIL's Sustainability Rating 2022 • Rejuvenating Cipla: After global expansion, acquisitions on cards • Cipla Health’s Maxirich ropes in Ayushmann Khurrana as brand ambassador • Innovation Of New Therapy Is The key Takeaway From Covid For Pharma | Umang Vohra • Our Chief Medical Officer, Dr Jaideep Gogtay shares his thoughts on why it is still too early to relax our guard • Cipla HSS Episode 11 Premiering on 19th May 2022 • Cipla launches 'RT Direct' Multiplex Real Time PCR kit for Covid-19 • Pills to wellness, Cipla is seeking a new identity • Leapfrogging into the future of Indian pharma • BS Awards for Corporate Excellence 2021: Samina Hamied lauds team effort • Samina Hamied - ET Businesswoman of the Year 2021 • Introducing #Evexpert - a feminine hygiene range of products • Healthcare Superstars - Register now to be a part of our upcoming Episode 10 • ESG and corporate performance of a company are linked: Geena Malhotra, Cipla • Berok Zindagi | Asthma ke liye #InhalersHainSahi | Sonali Bendre • Women In Science Series • Berok Zindagi | Asthma ke liye #InhalersHainSahi | Priyanshu Painyuli • Berok Zindagi | Asthma ke liye #InhalersHainSahi | Mandira Bedi • Berok Zindagi | Asthma ke liye #InhalersHainSahi | Satish Kaushik • Cipla Healthcare Superstars – Episode 9 - Asthma Management and its treatment during Covid times • 40th Annual JP Morgan Healthcare conference • Cipla receives EUA to launch drug Cipmolnu® (Molnupiravir 200 mg) in India to treat COVID-19 • Cipla Receives Final Approval for Lanreotide Injection • Cipla acquires stake in Clean Max Auriga Power LLP • Berok Zindagi | Asthma ke liye #InhalersHainSahi • GBKS - Breathe Free Educator • #WorldCOPDDay: Let's talk #LungAttack • Cipla launches Spirofy India's first pneumotach based portable wireless Spirometer for diagnosis of COPD and asthma indias first pneumotach based portable wireless spirometer for diagnosis of copd and asthma • Cipla ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Emerging Markets Index • Palliative care puts the patient at the centre • Cipla features in Forbes World's Best Employers 2021 list • IPA announces New Office Bearers for 2021-2023 • Eli Lilly and Cipla enter into a strategic partnership in India to enhance access to Lilly’s key diabetes products • Healthcare Superstars - Register now to be a part of our upcoming Episode 07 • Cipla and Kemwell Biopharma announce execution of a joint venture agreement for developing, manufacturing and commercialising biosimilars • Mental wellbeing at workplace: Drawing lessons from the Olympics - By Dr Raju Mistry • The Cipla Story Since 1935. Buy Now! - Amazon Store • The Cipla Story Since 1935. Buy Now! - Flipkart Store • Good Advice for Good Breathing during monsoon | Breathefree • Cipla receives final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05%) • On navigating talent challenges at the forefront of the pandemic: Cipla’s Dr. Raju Mistry • Cipla is proud to present the Fourth Integrated #AnnualReport in line with the commitment to long-term value creation and the philosophy of ‘Caring for Life’. • #COVICLAVE21 – 1st National Conference for healthcare practitioners on decoding the challenges of post Covid-19 complications • Dr. Jaideep Gogtay shares how the COVID19 pandemic has pushed the importance of lung health to the forefront of healthcare • An organisation with a diverse talent pool not only makes for good social sense but also makes for perfect business sense • Cipla receives final approval for generic version of Sunovion Pharmaceuticals, Inc.’s Brovana • How Cipla Is Shaping Lung Leadership Beyond Asthma, AMR Plans • Road to a Sustainable Future • Healthcare Superstars - Register now for Our Upcoming Episode • Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India • Roche partners with @Cipla for pan-India distribution of its EUA-approved investigational antibody cocktail (#casirivimab & #imdevimab) used in the treatment of #COVID19 • Making India breathe free beyond Covid-19